loadpatents
name:-0.28593802452087
name:-0.025966882705688
name:-0.039967060089111
Gallant; Michel Patent Filings

Gallant; Michel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gallant; Michel.The latest application filed is for "mannose derivatives for treating bacterial infections".

Company Profile
5.23.33
  • Gallant; Michel - Pierrefonds CA
  • Gallant; Michel - Pierre Fonds CA
  • Gallant; Michel - Kirkland CA
  • Gallant; Michel - Laval CA
  • Gallant; Michel - Aesrefends CA
  • Gallant; Michel - Montreal CA
  • Gallant, Michel - Nepean CA
  • Gallant; Michel - Rahway NJ
  • Gallant, Michel - Montreal-Quest CA
  • Gallant, Michel - Montreal-Ouest CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mannose Derivatives for Treating Bacterial Infections
App 20220135609 - Ramtohul; Yeeman K. ;   et al.
2022-05-05
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20220041621 - Clemens; Jeremy J. ;   et al.
2022-02-10
2,7-dibromospiro[fluorene-9,4'-piperidine] compounds
Grant 10,913,761 - Ramtohul , et al. February 9, 2
2021-02-09
Mannose Derivatives for Treating Bacterial Infections
App 20200270293 - Ramtohul; Yeeman K. ;   et al.
2020-08-27
Mannose derivatives for treating bacterial infections
Grant 10,669,298 - Ramtohul , et al.
2020-06-02
Mannose derivatives for treating bacterial infections
Grant 10,407,414 - Gallant , et al. Sept
2019-09-10
Mannose Derivatives for Treating Bacterial Infections
App 20190106450 - Ramtohul; Yeeman K. ;   et al.
2019-04-11
Mannose Derivatives for Treating Bacterial Infections
App 20180244658 - Gallant; Michel ;   et al.
2018-08-30
Mannose derivatives for treating bacterial infections
Grant 9,963,478 - Ramtohul , et al. May 8, 2
2018-05-08
Mannose derivatives for treating bacterial infections
Grant 9,890,176 - Dietrich , et al. February 13, 2
2018-02-13
Mannose derivatives for treating bacterial infections
Grant 9,598,454 - Ramtohul , et al. March 21, 2
2017-03-21
Mannose Derivatives for Treating Bacterial Infections
App 20160235775 - Ramtohul; Yeeman K. ;   et al.
2016-08-18
Mannose Derivatives For Treating Bacterial Infections
App 20140274930 - Dietrich; Evelyne ;   et al.
2014-09-18
Mannose Derivatives For Treating Bacterial Infections
App 20140243283 - Ramtohul; Yeeman K. ;   et al.
2014-08-28
Indole derivatives as CRTH2 receptor antagonists
Grant 8,637,671 - Colucci , et al. January 28, 2
2014-01-28
Mannose Derivatives For Treating Bacterial Infections
App 20130261077 - Bennani; Youssef Laafiret ;   et al.
2013-10-03
Bridged Lipoglycopeptides That Potentiate The Activity Of Beta-lactam Antibacterials
App 20130244929 - Gallant; Michel ;   et al.
2013-09-19
Case of renin inhibitors
Grant 8,343,968 - Wu , et al. January 1, 2
2013-01-01
Renin inhibitors
Grant 8,334,308 - Juteau , et al. December 18, 2
2012-12-18
Renin Inhibitors
App 20120046293 - BAYLY; CHRISTOPHER I. ;   et al.
2012-02-23
Renin Inhibitors
App 20120035214 - McKay; Daniel J. ;   et al.
2012-02-09
Renin inhibitors
Grant 8,076,359 - Dube , et al. December 13, 2
2011-12-13
Renin inhibitors
Grant 8,063,105 - Bayly , et al. November 22, 2
2011-11-22
Renin Inhibitors
App 20110263658 - Juteau; Helene ;   et al.
2011-10-27
Indole Derivatives As Crth2 Receptor Antagonists
App 20110172263 - Colucci; John ;   et al.
2011-07-14
Novel Case Of Renin Inhibitors
App 20100120859 - Wu; Tom Yao-Hsiang ;   et al.
2010-05-13
Renin Inhibitors
App 20100063091 - Dube; Daniel ;   et al.
2010-03-11
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
Grant 7,622,501 - Dufresne , et al. November 24, 2
2009-11-24
Renin Inhibitors
App 20090281103 - Bayly; Christopher I. ;   et al.
2009-11-12
8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
Grant 7,482,456 - Dube , et al. January 27, 2
2009-01-27
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors
App 20080242643 - Dufresne; Claude ;   et al.
2008-10-02
Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events
App 20080242722 - Dufresne; Claude ;   et al.
2008-10-02
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
App 20080070940 - Dube; Daniel ;   et al.
2008-03-20
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
Grant 7,342,024 - Dube , et al. March 11, 2
2008-03-11
4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
Grant 7,238,706 - Dube , et al. July 3, 2
2007-07-03
4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
App 20070099951 - Dube; Daniel ;   et al.
2007-05-03
8-(biaryl)quinoline PDE4 inhibitors
Grant 7,153,968 - Dube , et al. December 26, 2
2006-12-26
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
Grant 7,144,896 - Gallant , et al. December 5, 2
2006-12-05
8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
App 20060223850 - Dube; Daniel ;   et al.
2006-10-05
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
App 20060058316 - Dube; Daniel ;   et al.
2006-03-16
Use of phosphodiesterase-4 inhibitors as enhancers of cognition
App 20060040981 - Dube; Daniel ;   et al.
2006-02-23
Secure electronic file delivery system
App 20050267844 - Gallant, Michel ;   et al.
2005-12-01
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
App 20050245513 - Gallant, Michel ;   et al.
2005-11-03
8-(Biaryl)quinoline pde4 inhibitors
App 20050234238 - Dube, Daniel ;   et al.
2005-10-20
Substituted 8-arylquinolune PDE4 inhibitors
Grant 6,919,353 - Dube , et al. July 19, 2
2005-07-19
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
App 20050107402 - Dube, Daniel ;   et al.
2005-05-19
Substituted 8-arylquinolune pde4 inhibitors
App 20040162314 - Dube, Daniel ;   et al.
2004-08-19
Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
Grant 6,627,656 - Gallant , et al. September 30, 2
2003-09-30
Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
App 20020103226 - Deschenes, Denis ;   et al.
2002-08-01
Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
App 20020082266 - Gallant, Michel ;   et al.
2002-06-27
Prostaglandin receptor ligands
App 20010031766 - Belley, Michel ;   et al.
2001-10-18
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
Grant 6,242,493 - Gareau , et al. June 5, 2
2001-06-05
Method for identifying inhibitors for apopain based upon the crystal structure of the apopain: Ac-DEVD-CHO complex
Grant 5,834,228 - Becker , et al. November 10, 1
1998-11-10
Indole derivatives with affinity for the cannabinoid receptor
Grant 5,532,237 - Gallant , et al. July 2, 1
1996-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed